Pharming Group NV operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharming Group with three other
miscellaneous service companies in Europe:
Circassia Pharmaceuticals PLC
of the United Kingdom
sales of £10.80 million [US$13.17 million]
of which 95%
(11.20 million Euro [US$12.20 million]
of which 100%
was Royalty Income), and
based in Norway
(99.93 million Norwegian Kroner [US$12.06 million]
During the year ended December of 2015, sales at
Pharming Group were 10.83 million Euro (US$11.80 million).
decrease of 48.9%
versus 2014, when the company's sales were 21.19 million Euro.